Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4344 results

Sort By:

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Study ID: NCT06333314
Start Date: May 2024
End Date: September 2030
Study Type

Interventional

Study Phase

Phase 2

No. of Participants

120

Intervention / Treatment

Dostarlimab

Chemotherapy

Sponsor

UNICANCER

Source: clinicaltrials.gov

Share:
Add to list

Use of Allied-health Professionals to Improve Treatment of Disease

Study ID: NCT06337799
Start Date: October 2026
End Date: March 2030
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Research Pharmacist

Sponsor

University of Iowa

Source: clinicaltrials.gov

Share:
Add to list

Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico

Study ID: NCT06332209
Start Date: June 1, 2024
End Date: September 30, 2025
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Trauma Focused Cognitive Behavioral Therapy

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list

Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors

Study ID: NCT06336538
Start Date: July 1, 2024
End Date: January 31, 2025
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

31

Intervention / Treatment

MBCT

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Study ID: NCT06336642
Start Date: September 30, 2024
End Date: March 31, 2032
Study Type

Interventional

Study Phase

Phase 3

No. of Participants

150

Intervention / Treatment

SPOT-ON Early Start

SPOT-ON Delayed Start

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

Study ID: NCT06337032
Start Date: September 2024
End Date: March 2034
Study Type

Interventional

Study Phase

Phase 4

No. of Participants

350

Intervention / Treatment

F/TAF (High Dose Tablet)

F/TAF (Low Dose Tablet)

F/TAF (Lowest Dose Tablet)

F/TAF (High Dose TOS)

F/TAF (Low Dose TOS)

F/TAF (Lowest Dose TOS)

E/C/F/TAF

E/C/F/TAF (Low Dose)

Cobicistat (High Dose)

Cobicistat (Low Dose)

Cobicistat (TOS)

B/F/TAF (High Dose)

B/F/TAF (Low Dose)

B/F/TAF (High Dose TOS)

B/F/TAF (Low Dose TOS)

B/F/TAF (Lowest Dose TOS)

3rd ARV Agent

Nucleos(t)ide reverse transcriptase inhibitors (NRTI)

ATV

DRV

Lopinavir Boosted with ritonavir (LPV/r)

Sponsor

Gilead Sciences

Source: clinicaltrials.gov

Share:
Add to list

Physica TT Tibial Plate Follow up Study

Study ID: NCT06337123
Start Date: May 2024
End Date: December 2027
Study Type

Observational

Study Phase

N/A

No. of Participants

130

Intervention / Treatment

Device: Physica TT TIbial Plate and Physica Porous KR

Device: Physica TT TIbial Plate and Physica Porous PS

Sponsor

Limacorporate S.p.a

Source: clinicaltrials.gov

Share:
Add to list

Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)

Study ID: NCT06337162
Start Date: May 1, 2024
End Date: September 1, 2028
Study Type

Interventional

Study Phase

Phase 1

No. of Participants

15

Intervention / Treatment

INCB099280

Sponsor

Abramson Cancer Center at Penn Medicine

Source: clinicaltrials.gov

Share:
Add to list

Square Step Exercises in Healthy Young Adults

Study ID: NCT06331078
Start Date: August 1, 2024
End Date: August 1, 2025
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Square Stepping Exercise training

Aerobic Exercise Training

Sponsor

Fenerbahce University

Source: clinicaltrials.gov

Share:
Add to list

Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures: A Multicenter Randomized Controlled Trial

Study ID: NCT06337292
Start Date: May 1, 2024
End Date: December 31, 2028
Study Type

Interventional

Study Phase

Phase 3

No. of Participants

352

Intervention / Treatment

Incisional Negative Pressure Wound Therapy (NPWT)

Sponsor

Major Extremity Trauma Research Consortium

Source: clinicaltrials.gov

Share:
Add to list